Accès gratuit
Med Sci (Paris)
Volume 21, Numéro 2, Février 2005
Page(s) 156 - 161
Section M/S revues
Publié en ligne 15 février 2005
  1. Capaldi RA, Halphen DG, Zhang YZ, Yanamura W. Complexity and tissue specificity of the mitochondrial respiratory chain. J Bioenerg Biomembr 1988; 20 : 291–311.
  2. Pebay-Peyroula E, Dahout-Gonzalez C, Kahn R, et al. Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 2003; 426 : 39–44.
  3. Stepien G, Torroni A, Chung A, et al. Differential expression of adenine nucleotide translocator isoforms in mammalian tissues and during cell differentiation. J Biol Chem 1992; 267 : 14592–7.
  4. Li K, Hodge JA, Wallace DC. OXBOX, a positive transcriptional element of the heart-skeletal muscle ADP/ATP translocator gene. J Biol Chem 1990; 265 : 20585–8.
  5. Giraud S, Bonod-Bidaud C, Wesolowski-Louvel M, Stepien G. Expression of human ANT2 gene in highly proliferative cells : GRBOX, a new transcriptional element, is involved in the regulation of glycolytic ATP import into mitochondria. J Mol Biol 1998; 281 : 409–18.
  6. Luciakova K, Barath P, Poliakova D, et al. Repression of the human adenine nucleotide translocase-2 gene in growth-arrested human diploid cells : the role of nuclear factor-1. J Biol Chem 2003; 278 : 30624–33.
  7. Ku DH, Kagan J, Chen ST, et al. The human fibroblast adenine nucleotide translocator gene : molecular cloning and sequence. J Biol Chem 1990; 265 : 16060–3.
  8. Barath P, Luciakova K, Hodny Z, et al. The growth-dependent expression of the adenine nucleotide translocase-2 (ANT2) gene is regulated at the level of transcription and is a marker of cell proliferation. Exp Cell Res 1999; 248 : 583–8.
  9. Jang JY, Lee CE. Mitochondrial adenine nucleotide translocator 3 is regulated by IL-4 and IFN-gamma via STAT-dependent pathways. Cell Immunol 2003; 226 : 11–9.
  10. Amiri H, Karlberg O, Andersson SE. Deep origin of plastid/parasite ATP/ADP translocases. J Mol Evol 2003; 56 : 137–50.
  11. Mathupala SP, Rempel A, Pedersen PL. Glucose catabolism in cancer cells : identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J Biol Chem 2001; 276 : 43407–12.
  12. Pedersen PL, Mathupala S, Rempel A, et al. Mitochondrial bound type II hexokinase : a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention. Biochim Biophys Acta 2002; 1555 : 14–20.
  13. Napoli L, Bordoni A, Zeviani M, et al. A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. Neurology 2001; 57 : 2295–8.
  14. Siciliano G, Tessa A, Petrini S, et al. Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord 2003; 13 : 162–5.
  15. Jordens EZ, Palmieri L, Huizing M, et al. Adenine nucleotide translocator 1 deficiency associated with Sengers syndrome. Ann Neurol 2002; 52 : 95–9.
  16. Graham BH, Waymire KG, Cottrell B, et al. A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat Genet 1997; 16 : 226–34.
  17. ;Faustin B, Rossignol R, Rocher C, et al. Mobilization of adenine nucleotide translocators as molecular bases of the biochemical threshold effect observed in mitochondrial diseases. J Biol Chem 2004; 279 : 20411–21.
  18. Kokoszka JE, Waymire KG, Levy SE, et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004; 427 : 461–5.
  19. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997; 18 : 44–51.
  20. Brenner C, Cadiou H, Vieira HL, et al. Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator. Oncogene 2000; 19 : 329–36.
  21. Bauer MK, Schubert A, Rocks O, Grimm S. Adenine nucleotide translocase-1, a component of the permeability transition pore, can dominantly induce apoptosis. J Cell Biol 1999; 147 : 1493–502.
  22. Zamora M, Granell M, Mampel T, Vinas O. Adenine nucleotide translocase 3 (ANT3) overexpression induces apoptosis in cultured cells. FEBS Lett 2004; 563 : 155–160.
  23. Ara G, Kusumoto T, Korbut TT, et al. Cis-diamminedichloroplatinum(II) resistant human tumor cell lines are collaterally sensitive to PtCl4(Rh-123)2 : evidence for mitochondrial involvement. Cancer Res 1994; 54 : 1497–502.
  24. Harper ME, Antoniou A, Villalobos-Menuey E, et al. Characterization of a novel metabolic strategy used by drug-resistant tumor cells. Faseb J 2002; 16 : 1550–7.
  25. Ludwig B, Bender E, Arnold S, et al. Cytochrome C oxidase and the regulation of oxidative phosphorylation. Chem Biochem 2001; 2 : 392–403.
  26. Chevrollier A, Loiseau D, Gautier F, et al. ANT2 expression under hypoxic conditions produces opposite cell-cycle behavior in 143B and HepG2 cancer cells. Mol Carcinogen 2005; 42 : 1–8.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.